The CEO of Novo Nordisk faced pointed questions about the cost of Ozempic and Wegovy on Capitol Hill Tuesday, as lawmakers pressed the Danish pharmaceutical giant to cut the prices of its blockbuster diabetes and obesity medications.
More Stories
Elon Musk says humans could soon be heading to Mars. This former astronaut begs to differ.
“I wish he was right, but the reality is that Mars travel, for people, is very risky right now and...
Why having kids is such a struggle for families making less than $166,000
Families who pay for child care now spend an average of 18.6% of their income on this service.
Fed’s favorite PCE inflation gauge likely to show cooling inflation and back further rate cuts
The rate of U.S. inflation using the Federal Reserve’s favorite gauge is likely to show prices rising in August slightly...
Trump floats manufacturing ambassador, while his Deere tariff threat draws flak from Mark Cuban
Republican presidential nominee Donald Trump on Tuesday offered promises to reverse offshoring by U.S. manufacturers, while Democratic rival Kamala Harris’s...
5-year Treasurys tend to beat cash after first Fed rate cut, this chart shows
For investors considering moving out of cash now that the Federal Reserve has started cutting interest rates, returns from the...
Costco made these subtle changes, adding enough ‘friction’ to prompt a downgrade
Shares of Costco Wholesale Corp. pulled back Tuesday, after Truist analyst Scot Ciccarelli recommended investors stop buying due to concerns...